Christopher Heery, CHIEF MEDICAL OFFICER at Arcellx, Inc. (ACLX), sold 35,736 shares at $50.99 ($1.8M) on 2024-05-01, disclosed to the SEC on 2024-05-03.
Scheduled sale ($1.8M) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.99 | 7,087 | $361K | 19.7% |
| 2 | $50.99 | 7,087 | $361K | 19.7% |
| 3 | $51.48 | 10,481 | $540K | 29.4% |
| 4 | $51.48 | 10,481 | $540K | 29.4% |
| 5 | $52.63 | 500 | $26K | 1.4% |
| 6 | $53.55 | 100 |
| $5K |
| 0.3% |
| Total | $51.31 avg | 35,736 | $1.8M | 100% |
| Filing → |
| ACLX | SELL | 2026-01-12 | $393K | — | Filing → |
| ACLX | SELL | 2025-11-17 | $31K | — | Filing → |
| ACLX | SELL | 2025-09-30 | $2.9M | — | Filing → |